Inside the research
Corteva, Inc.
CTVA Research profile · latest available data
Price overview
$78.52
▼ -0.93 (-1.2%)
| 52w hi | $90.32 |
|---|---|
| 52w lo | $60.43 |
| Vol | 4.16M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.03
| Short | +0.19 |
|---|---|
| Medium | -0.09 |
| Long | -0.35 |
computed 2026-09-27
Key fundamentals
Corteva, Inc.
Basic Materials · Agricultural Inputs
| Market cap | $52.39B |
|---|---|
| Enterprise value | $55.14B |
| Trailing P/E | 47.59x |
| Forward P/E | 19.04x |
| EV / EBITDA | 12.90x |
| P / S (ttm) | 2.94x |
| Profit margin | 5.7% |
| Return on equity | 4.3% |
| Revenue growth | -1.2% |
| Earnings growth | -9.9% |
| Debt / equity | 19.19 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.09 | |
| Sector | -0.02 | |
| Technical | +0.07 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. The company was founded in 1802 and is headquartered in Indianapolis, Indiana.
Risk Metrics
| Beta vs SPX | 0.49 |
|---|---|
| Corr SPX | 0.30 |
| Annual vol | 26.3% |
| Annual ret | +19.0% |
| Sharpe | 0.72 |
| Max DD | -20.9% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $88.29 |
|---|---|
| High / Low | $97.00 / $77.00 |
| Median | $90.00 |
| Analysts | 21 |
| Strong Buy | 3 | |
|---|---|---|
| Buy | 12 | |
| Hold | 7 | |
| Sell | 0 | |
| Strong Sell | 0 |
Recent rating actions
| 2026-05-07 | UBS | → Neutral |
| 2026-05-07 | Citigroup | → Neutral |
| 2026-04-24 | RBC Capital | → Outperform |
| 2026-04-22 | Oppenheimer | → Outperform |
| 2026-04-21 | Wells Fargo | → Overweight |
| 2026-04-09 | UBS | → Neutral |
Officers & Board
| CEO | Chuck Magro since 2021 |
|---|
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-14 | Reg FD Disclosure | read |
| 2026-08-06 | Reg FD Disclosure, Other Material Event… | read |
| 2026-07-30 | Earnings Release, Exhibits | read |
| 2026-06-29 | Officer / Director Change, Reg FD Disclosure… | read |
| 2026-05-05 | Earnings Release, Exhibits | read |
| 2026-05-01 | Shareholder Vote | read |
| 2026-04-14 | Officer / Director Change, Reg FD Disclosure… | read |
| 2026-02-03 | Earnings Release, Exhibits | read |
| 2025-11-04 | Earnings Release, Exhibits | read |
| 2025-10-01 | Earnings Release, Exhibits | read |
| 2025-08-26 | Officer / Director Change, Reg FD Disclosure… | read |
| 2025-08-06 | Earnings Release, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-31 | Policinski Christopher J. | Director | Grant | 413 | $32.50K |
| 2026-07-31 | Nayyar Nayaki R | Director | Grant | 413 | $32.50K |
| 2026-07-31 | Giesselman Janet Plaut | Director | Grant | 98 | $7.75K |
| 2026-06-01 | KISSAM LUTHER C IV | Officer, CEO, Crop Protec | Grant | 24.14K | — |
| 2026-04-30 | Nayyar Nayaki R | Director | Grant | 401 | $32.50K |
| 2026-04-30 | Lutz Marcos M | Director | Withheld for tax | 906 | $73.40K |
| 2026-04-30 | Giesselman Janet Plaut | Director | Grant | 96 | $7.75K |
| 2026-04-30 | Engel Klaus A | Director | Withheld for tax | 906 | $73.40K |
| 2026-04-28 | Ward Pat | Director | Grant | 2.35K | — |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 8 |
| Top-5 share | 98.5% |
| HHI | 4,189 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| Fidelity / FMR LLC | $3.48B | 41.07M |
| State Street Corp | $3.24B | 38.26M |
| Capital Research / Capital World | $246.95M | 2.92M |
| AQR Capital Management | $177.22M | 2.12M |
| Millennium Management | $110.99M | 1.31M |
| Citadel Advisors | $87.90M | 1.04M |
| Bridgewater Associates | $20.58M | 243.05K |
| T. Rowe Price Group | $410.64K | 4.85M |
As of 2026-06-30
Connections
Subsidiarys: Pioneer Hi-Bred International
Dividends
| Yield (TTM) | 0.46% |
|---|---|
| $ / share (TTM) | $0.36 |
| 5y CAGR | +6.1% |
Annual dividend per share
| 2021 | $0.54 |
|---|---|
| 2022 | $0.58 |
| 2023 | $0.62 |
| 2024 | $0.66 |
| 2025 | $0.70 |
| 2026 | $0.18 |
SEC Filings
The Long Run
FY 2019–2025 · 7 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $17.23B | +31.1% | |
| Net income | $1.09B | -7.4% | |
| Cash from ops | $1.77B | -11.5% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $78.97 | $78.98 | $77.33 | $78.52 | 4.16M |
| Sep 24 | $81.53 | $81.53 | $79.06 | $79.45 | 3.50M |
| Sep 23 | $79.83 | $82.26 | $79.61 | $80.42 | 5.55M |
| Sep 22 | $79.07 | $81.49 | $78.59 | $80.34 | 4.09M |
| Sep 21 | $80.67 | $81.05 | $78.85 | $79.11 | 2.88M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →